MIM
MIRM icon

Monashee Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Monashee Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,000
Closed -$630K – 56
2022
Q3 		$630K Buy
+30,000
New +$722K 0.23% 43
2021
Q1 		– Sell
-125,000
Closed -$2.18M – 409
2020
Q4 		$2.18M Buy
+125,000
New +$2.46M 0.29% 89

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Monashee Investment Management's MIRM Position: Q4 2022 in Review

Monashee Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2022, closing a stake of 30,000 shares — an estimated $630K sold.

Monashee Investment Management first reported a position in MIRM in Q4 2020 and held it in 2 quarters. The position peaked at $2.18M in Q4 2020. 104 funds tracked by Wall St. Rank hold MIRM as of Q4 2022.

  • Monashee Investment Management reported no remaining Mirum Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Monashee Investment Management sold 30,000 Mirum Pharmaceuticals shares in Q4 2022, an estimated $630K.
  • Monashee Investment Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Monashee Investment Management's Mirum Pharmaceuticals position peaked at $2.18M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2022.

Based on Monashee Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.